A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers
暂无分享,去创建一个
Jeffrey N. Martin | H. Hatano | J. McCune | E. Sinclair | M. Busch | S. Deeks | A. Landay | P. Hunt | P. Norris | J. Martinson | B. Emu | Cicely Brooks | Jeffrey N. Martin | M. Busch
[1] R. Redfield,et al. Hepatitis C infection in HIV-1 natural viral suppressors , 2010, AIDS.
[2] Rachel E. Owen,et al. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses , 2010, AIDS.
[3] M. Leal,et al. CD4(+)CD25(+/hi)CD127(lo) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons. , 2010, The Journal of infectious diseases.
[4] Jeffrey N. Martin,et al. Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease , 2010, PloS one.
[5] F. Pereyra,et al. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. , 2009, The Journal of infectious diseases.
[6] Jeffrey N. Martin,et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis , 2009, AIDS.
[7] D. Costagliola,et al. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV , 2009, AIDS.
[8] C. Wachihi,et al. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. , 2009, The Journal of infectious diseases.
[9] R. Detels,et al. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. , 2009, AIDS research and human retroviruses.
[10] Philippe Froguel,et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). , 2009, The Journal of infectious diseases.
[11] S. Fischer,et al. Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness , 2009, Journal of Virology.
[12] H. Schuitemaker,et al. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection , 2009, AIDS.
[13] C. Hallahan,et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. , 2008, Immunity.
[14] Devan V Mehrotra,et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.
[15] B. Agan,et al. HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles , 2008, PloS one.
[16] Todd M. Allen,et al. HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.
[17] Jeffrey N. Martin,et al. Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy , 2008, Journal of Virology.
[18] R. Siliciano,et al. Evidence of CD8+ T-Cell-Mediated Selective Pressure on Human Immunodeficiency Virus Type 1 nef in HLA-B*57+ Elite Suppressors , 2008, Journal of Virology.
[19] R. Siliciano,et al. Preservation of FoxP3+ Regulatory T Cells in the Peripheral Blood of Human Immunodeficiency Virus Type 1-Infected Elite Suppressors Correlates with Low CD4+ T-Cell Activation , 2008, Journal of Virology.
[20] R. Siliciano,et al. Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor , 2008, Journal of Virology.
[21] Steven G. Deeks,et al. HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control , 2008, Journal of Virology.
[22] M. Battaglia,et al. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. , 2008, International immunology.
[23] R. Siliciano,et al. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors , 2008, AIDS.
[24] Terri Wrin,et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. , 2008, The Journal of infectious diseases.
[25] Patrick Taffé,et al. In Vitro Whole-Genome Analysis Identifies a Susceptibility Locus for HIV-1 , 2008, PLoS biology.
[26] D. Scott‐Algara,et al. Preserved Central Memory and Activated Effector Memory CD4+ T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study , 2007, Journal of Virology.
[27] E. Rosenberg,et al. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction , 2007, Nature Immunology.
[28] P. Goepfert,et al. Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines , 2007, Journal of Virology.
[29] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[30] E. Shevach,et al. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. , 2007, Blood.
[31] Amalio Telenti,et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.
[32] Asier Sáez-Cirión,et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.
[33] M. Roncarolo,et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. , 2007, International immunology.
[34] A. Fauci,et al. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals , 2007, Proceedings of the National Academy of Sciences.
[35] J. McCune,et al. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. , 2007, Journal of immunological methods.
[36] R. Siliciano,et al. Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors , 2006, Journal of Virology.
[37] C. Chougnet,et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. , 2006, Blood.
[38] Jeffrey N. Martin,et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses , 2006, AIDS.
[39] H. Stein,et al. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. , 2006, Blood.
[40] W. Selby,et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells , 2006, The Journal of experimental medicine.
[41] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[42] H. Fleury,et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans , 2006, Retrovirology.
[43] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[44] Robert F. Siliciano,et al. Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations , 2006, The Journal of experimental medicine.
[45] B. Vuylsteke,et al. Suppressed cellular alloimmune responses in HIV‐exposed seronegative female sex workers , 2006, Clinical and experimental immunology.
[46] D. Watkins,et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. , 2006, The Journal of infectious diseases.
[47] L. Meyer,et al. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters , 2005, AIDS.
[48] J. Kahn,et al. Seroconversion following nonoccupational postexposure prophylaxis against HIV. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] Jeffrey N. Martin,et al. Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment , 2005, Journal of Virology.
[50] H. Schuitemaker,et al. Low-Level CD4+ T Cell Activation Is Associated with Low Susceptibility to HIV-1 Infection1 , 2005, The Journal of Immunology.
[51] C. Rouzioux,et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] Louis J. Picker,et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.
[53] J. Metcalf,et al. In vivo expansion of CD4+CD45RO–CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients , 2005 .
[54] N. Jones,et al. Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation1 , 2005, The Journal of Immunology.
[55] Y. Lévy,et al. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. , 2004, Blood.
[56] Peter Hunt,et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.
[57] S. Ziegler,et al. CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status , 2004, The Journal of experimental medicine.
[58] Mark S. Sundrud,et al. HIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells , 2004, PLoS biology.
[59] E. Rosenberg,et al. Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides , 2004, Journal of Virology.
[60] M. Lederman,et al. Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection1 , 2004, The Journal of Immunology.
[61] Anthony D Kelleher,et al. Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection. , 2004, Blood.
[62] D. Nixon,et al. Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens , 2004, Journal of Virology.
[63] T. Chun,et al. Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[64] G. Pantaleo,et al. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. , 2004, Blood.
[65] Jeffrey N. Martin,et al. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. , 2004, The Journal of infectious diseases.
[66] M. Lederman,et al. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. , 2003, The Journal of infectious diseases.
[67] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[68] John W. Mellors,et al. Predictive Value of Immunologic and Virologic Markers After Long or Short Duration of HIV‐1 Infection , 2002, Journal of acquired immune deficiency syndromes.
[69] H. Schuitemaker,et al. Naturally HIV-1 seroconverters with lowest viral load have best prognosis, but in time lose control of viraemia. , 2002, AIDS.
[70] L. Kalish,et al. Qualitative and Quantitative PCR Measures of Cytomegalovirus in Patients With Advanced HIV Infection Who Require Transfusions , 2001, Journal of acquired immune deficiency syndromes.
[71] J. Goedert,et al. Characterization of high-risk HIV-1 seronegative hemophiliacs. , 2001, Clinical immunology.
[72] C. Rouzioux,et al. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection , 2000, AIDS.
[73] D. Cooper,et al. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. , 1999, The Journal of infectious diseases.
[74] J. Mills,et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. , 1999, The New England journal of medicine.
[75] J V Giorgi,et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.
[76] S. Rowland-Jones,et al. Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1 , 1999, Journal of Virology.
[77] R. Detels,et al. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[78] G A Satten,et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. , 1998, JAMA.
[79] J. MacKinnon,et al. Estimation and inference in econometrics , 1994 .
[80] J. Giorgi,et al. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. , 1993, Journal of immunology.
[81] Jeffrey N. Martin,et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. , 2008, The Journal of infectious diseases.
[82] H. Stein,et al. Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. , 2006, European journal of immunology.
[83] A. Kelleher,et al. OR.8. Expression of Il-2 and Il-7 Receptors Discriminates Between Human Regulatory and Activated T-Cells Within CD45RA and CD45RO Compartments , 2006 .
[84] M. Schilham,et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. , 2005, Human immunology.
[85] J. Metcalf,et al. In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. , 2005, The Journal of clinical investigation.